subject: Opportunity China's pharmaceutical enterprises in Africa: the market attractive policy concessions - medicine, Africa - the pharmaceutical [print this page] Opportunity China's pharmaceutical enterprises in Africa: the market attractive policy concessions - medicine, Africa - the pharmaceutical
Thousands of miles outside the East African countries of Kenya, have called "contecxin (Elcoteq new)," the black girl, contecxin dictionary in Kenya is not found, it is the little girl's mother to thank China of antimalarial drugs?? Elcoteq new to help her get rid of the malaria, so she has a child and for the memorial.
From April 1963 the Chinese government dispatched medical teams to Africa since the first Chinese medicine with this mysterious continent have forged a bond. The end of 2005, China has sent more than 15,000 medical teams aid in Africa, Chinese pharmaceutical companies also worked in Zanzibar, Mali, Cte d'Ivoire, Kenya, Egypt, Sudan and other countries invested in pharmaceutical companies.
Had African envoys said that the next 5 years to 8 years will be Chinese companies investing in Africa's "Golden Age", a strong economic complementarity between China and Africa, great potential for cooperation. Commerce Department estimated in 2006, Sino-African trade volume will exceed 50 billion U.S. dollars, the fifth consecutive year to achieve high growth.
Market offers attractive policy Africa is a seriously underserved areas, most of the drugs to be imported. As the overall level of economic development lags in per capita consumption level of drugs in addition to South Africa, Libya and a few other rich countries is relatively high, the vast majority of African countries, the level of per capita drug use is very low, many patients without drug treatment. WHO data show that the African continent the total number of AIDS has more than 20 million. Malaria is also prevalent in African countries, schistosomiasis and other parasitic diseases to spread, tuberculosis, cholera, infectious diseases remain high, leading to millions of deaths each year. Therefore, the mortality rate of the population of Africa the forefront of the world on every continent. Africa's weak industrial base of Traditional Chinese Medicine, in addition to a few countries such as South Africa and Egypt, the basis of the pharmaceutical industry is relatively better, other African countries, the major drugs produced by some commonly used antibiotics and antipyretic analgesic and other generic drugs, dosage form homogeneous, non-matching conditions for the local industry, manufacture of pharmaceutical raw materials and packaging materials, dependence on imports, production of essential medicines in their consumption. Nigeria as an example, there are currently 160 Chinese enterprises and enterprises long-term capacity utilization remained at 40%. Lack of research capacity and adequate capital investment, the country can only produce a simple generic drugs, and mostly no trademark or patent has expired medicines, such as paracetamol, metronidazole, pyrimethamine, vitamin, pain agents, antibiotics, such as glucose and saline.
State Export-Import Bank of the data showed that more than 800 companies in China to invest in Africa, 1 September this year, Sino-African trade volume reached 40.6 billion U.S. dollars, of which China exports to Africa more than 18.7 billion U.S. dollars, imports from Africa more than 21.8 billion U.S. dollars. As at the end of 2005, Chinese investment has reached 6.27 billion U.S. dollars. It is because of the huge African market in the pharmaceutical supply capacity needs and their own poor, in recent years, Africa has become China's pharmaceutical enterprises "going out" one of the first choice. China Pharmaceutical Group, Shanghai Fuxing Group, Guilin Pharmaceutical, Hualijituan Kunming Pharmaceuticals, Beijing Holley Elcoteq medicine has limited liability companies build factories in Africa, set up marketing offices.
Present, in the investment business in Africa is not only to provide preferential loans and preferential export buyer's credit to encourage support for the policy, also established in 11 countries in Africa Investment and Trade Promotion Center, which has overall responsibility for Chinese entrepreneurs in Africa, visa, business meetings, etc.; with 25 African countries signed the "Government Loan Agreement between the discount offer."
Medicine as a health industry, African governments on investment in the pharmaceutical industry more attention. States have introduced various incentives to encourage policies. Instance, some countries adopt tax measures to the project; from industry of the date of commissioning or opening 5 to 10 years or even longer period of exemption from corporate income tax; in the provision of duty-free period on the investment of equipment and the production of goods raw materials, intermediate means of production such as exemption from all customs duties and other import duties; exempt from export duty on all projects and industrial production tax and similar taxes; the same time to the project land and depreciation benefits and so on. In addition to preferential policies granted by the host governments, under the jurisdiction of each city there are some local preferential policies.
